The Genes2ME diagnostic company announced Tuesday that they had developed a real -time PCR -based kit for the Monkeypox virus. The company said that its multiplexed Pox-Q RT-PCR kit produces results in less than 50 minutes with a high precision rate.
“This unprecedented time underlines the importance of diagnostic tests in the preparation and preparation of health safety. Understanding the value of time, we have launched this PCR RT for Monkeypox, which will give the result in less than 50 minutes With the greatest precision, “said Neeraj Gupta, CEO and founder of Genes2me, in a statement.
Gupta said the company currently has the “ability to manufacture 5 million test kits in a week, and up to 2 million tests can be extended in one day with additional demand.”Amid more than 16,000 cases of Monkeoypox that are reported from 75 countries, including four India, the World Health Organization (WHO) has declared that the outbreak is a public health emergency of international concern.
WHO recommended that the type of sample for Monkeypox laboratory confirmation is skin lesion material, including injury surface and exudate swabs, roofs of more than one injury or lesion scabs.Therefore, for the detection of monkeoypox, dry swab swit and viral transport can be used, a solution used to preserve virus samples after collection.
The kit is available in the standard version for any commonly available RT-PCR instrument and the Care Point Format on the GENES2ME RAPI-q HT RT-PCR device.The attention point solution can be used for detection in multiple sites, including hospitals, airports, diagnostic laboratories and health camps, among others, the company said.